EU regulator approves Pfizer’s COVID-19 pill for high-risk groups

On Thursday, the European Union’s drug regulator approved Pfizer’s antiviral pill to combat COVID-19 for high-risk adults as the bloc works to combat the omicron variant. The European Medicines Agency (EMA) offered conditional approval for the…